Latest Insider Transactions at Medtronic PLC (MDT)
This section provides a real-time view of insider transactions for Medtronic PLC (MDT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Medtronic plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Medtronic plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 02
2023
|
Andrea Jo Goldsmith Director |
SELL
Payment of exercise price or tax liability
|
Direct |
169
-2.63%
|
$15,210
$90.23 P/Share
|
|
May 02
2023
|
Randall J Hogan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
169
-2.76%
|
$15,210
$90.23 P/Share
|
|
May 02
2023
|
Craig Arnold Director |
SELL
Payment of exercise price or tax liability
|
Direct |
169
-0.46%
|
$15,210
$90.23 P/Share
|
|
May 02
2023
|
Scott C Donnelly Director |
SELL
Payment of exercise price or tax liability
|
Direct |
169
-1.01%
|
$15,210
$90.23 P/Share
|
|
May 02
2023
|
Kevin E Lofton Director |
SELL
Payment of exercise price or tax liability
|
Direct |
169
-3.88%
|
$15,210
$90.23 P/Share
|
|
May 01
2023
|
Kendall J Powell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,930
+4.59%
|
$173,700
$90.68 P/Share
|
|
May 01
2023
|
Denise M Oleary Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,930
+2.54%
|
$173,700
$90.68 P/Share
|
|
May 01
2023
|
Elizabeth G Nabel Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,930
+12.27%
|
$173,700
$90.68 P/Share
|
|
May 01
2023
|
Richard H Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,930
+1.68%
|
$173,700
$90.68 P/Share
|
|
May 01
2023
|
Andrea Jo Goldsmith Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,930
+23.07%
|
$173,700
$90.68 P/Share
|
|
May 01
2023
|
Randall J Hogan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,930
+23.94%
|
$173,700
$90.68 P/Share
|
|
May 01
2023
|
Craig Arnold Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,930
+5.03%
|
$173,700
$90.68 P/Share
|
|
May 01
2023
|
Scott C Donnelly Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,930
+10.33%
|
$173,700
$90.68 P/Share
|
|
May 01
2023
|
Lidia Fonseca Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,624
+50.0%
|
$146,160
$90.68 P/Share
|
|
May 01
2023
|
Kevin E Lofton Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,930
+30.68%
|
$173,700
$90.68 P/Share
|
|
Apr 18
2023
|
Gregory L Smith EVP Global Ops & Supply Chain |
SELL
Payment of exercise price or tax liability
|
Direct |
74
-0.26%
|
$5,920
$80.71 P/Share
|
|
Apr 05
2023
|
Gregory L Smith EVP Global Ops & Supply Chain |
SELL
Payment of exercise price or tax liability
|
Direct |
6,866
-19.37%
|
$549,280
$80.27 P/Share
|
|
Feb 01
2023
|
Jennifer M Kirk Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
672
-6.23%
|
$57,120
$85.77 P/Share
|
|
Dec 13
2022
|
Sean Salmon EVP & President Cardiovascular |
SELL
Open market or private sale
|
Direct |
16,631
-31.55%
|
$1,330,480
$80.5 P/Share
|
|
Dec 13
2022
|
Sean Salmon EVP & President Cardiovascular |
BUY
Exercise of conversion of derivative security
|
Direct |
16,631
+13.25%
|
$914,705
$55.32 P/Share
|
|
Dec 09
2022
|
Ivan K Fong EVP GENERAL COUNSEL & SECR |
SELL
Payment of exercise price or tax liability
|
Direct |
5,206
-13.69%
|
$406,068
$78.59 P/Share
|
|
Dec 07
2022
|
Robert John White EVP & Pres. Medical Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
348
-0.95%
|
$27,492
$79.04 P/Share
|
|
Dec 07
2022
|
Brett A. Wall EVP & Pres Neuroscience |
SELL
Payment of exercise price or tax liability
|
Direct |
337
-1.31%
|
$26,623
$79.04 P/Share
|
|
Dec 07
2022
|
Sean Salmon EVP & President Cardiovascular |
SELL
Payment of exercise price or tax liability
|
Direct |
300
-0.82%
|
$23,700
$79.04 P/Share
|
|
Oct 14
2022
|
Hoedt Rob Ten EVP and Pres. Global Regions |
SELL
Open market or private sale
|
Direct |
2,404
-5.24%
|
$194,724
$81.54 P/Share
|
|
Oct 14
2022
|
Hoedt Rob Ten EVP and Pres. Global Regions |
BUY
Exercise of conversion of derivative security
|
Direct |
2,404
+4.98%
|
$98,564
$41.6 P/Share
|
|
Aug 01
2022
|
Gregory L Smith EVP Global Ops & Supply Chain |
BUY
Grant, award, or other acquisition
|
Direct |
5,587
+13.84%
|
-
|
|
Aug 01
2022
|
Brett A. Wall EVP & Pres Neuroscience |
BUY
Grant, award, or other acquisition
|
Direct |
7,521
+22.68%
|
-
|
|
Aug 01
2022
|
Robert John White EVP & Pres. Medical Surgical |
BUY
Grant, award, or other acquisition
|
Direct |
8,595
+19.12%
|
-
|
|
Aug 01
2022
|
Hoedt Rob Ten EVP and Pres. Global Regions |
BUY
Grant, award, or other acquisition
|
Direct |
7,306
+14.39%
|
-
|
|
Aug 01
2022
|
Carol A Surface EVP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,157
+16.45%
|
-
|
|
Aug 01
2022
|
Sean Salmon EVP & President Cardiovascular |
BUY
Grant, award, or other acquisition
|
Direct |
8,595
+19.18%
|
-
|
|
Aug 01
2022
|
Karen L Parkhill EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,744
+25.76%
|
-
|
|
Aug 01
2022
|
Geoffrey Martha Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
28,471
+21.74%
|
-
|
|
Aug 01
2022
|
Jennifer M Kirk Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,364
+18.19%
|
-
|
|
Aug 01
2022
|
Ivan K Fong EVP GENERAL COUNSEL & SECR |
BUY
Grant, award, or other acquisition
|
Direct |
6,941
+15.54%
|
-
|
|
Jul 29
2022
|
Brett A. Wall EVP & Pres Neuroscience |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,493
-29.25%
|
-
|
|
Jul 29
2022
|
Robert John White EVP & Pres. Medical Surgical |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,397
-30.87%
|
-
|
|
Jul 29
2022
|
Hoedt Rob Ten EVP and Pres. Global Regions |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,641
-21.04%
|
-
|
|
Jul 29
2022
|
Carol A Surface EVP, Chief HR Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,920
-27.35%
|
-
|
|
Jul 29
2022
|
Sean Salmon EVP & President Cardiovascular |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,808
-17.38%
|
-
|
|
Jul 29
2022
|
Karen L Parkhill EVP & Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
15,151
-42.84%
|
-
|
|
Jul 29
2022
|
Geoffrey Martha Chairman and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
23,410
-24.03%
|
-
|
|
Jul 29
2022
|
John R Liddicoat EVP & President of Americas |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,543
-14.9%
|
-
|
|
May 03
2022
|
Craig Arnold Director |
SELL
Payment of exercise price or tax liability
|
Direct |
262
-0.76%
|
$26,986
$103.11 P/Share
|
|
May 03
2022
|
Scott C Donnelly Director |
SELL
Payment of exercise price or tax liability
|
Direct |
262
-1.73%
|
$26,986
$103.11 P/Share
|
|
May 03
2022
|
Randall J Hogan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
262
-5.94%
|
$26,986
$103.11 P/Share
|
|
May 03
2022
|
Kevin E Lofton Director |
SELL
Payment of exercise price or tax liability
|
Direct |
161
-6.35%
|
$16,583
$103.11 P/Share
|
|
May 03
2022
|
Elizabeth G Nabel Director |
SELL
Payment of exercise price or tax liability
|
Direct |
262
-2.17%
|
$26,986
$103.11 P/Share
|
|
May 03
2022
|
Denise M Oleary Director |
SELL
Payment of exercise price or tax liability
|
Direct |
262
-0.37%
|
$26,986
$103.11 P/Share
|